TGLS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TGLS is not a good buy right now for an impatient investor. The setup is still technically bearish (downtrend intact with weakening momentum), and the data-driven short-term outlook points to limited upside near-term with higher risk of further downside over the next month. A better buy would be after a clear trend reversal (reclaiming the pivot/short MAs and MACD turning up), which is not present today.
Trend is bearish: moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), confirming price is in a broader downtrend. Momentum is also bearish: MACD histogram at -0.424 is below zero and negatively expanding, implying selling pressure is still increasing rather than stabilizing. RSI(6) at ~30.1 is near oversold, which can produce bounces, but by itself is not a reversal signal while MACD/MA structure stays bearish. Key levels: current post-market ~50.12 sits below the pivot 50.874 (still under a key reclaim level). Immediate support is S1 48.517, then S2 47.061; resistance is R1 53.231 then R2 54.687. The pattern-based projection suggests modest near-term upside (next day/week) but a negative 1-month bias (-3.51%), consistent with the downtrend.
Intellectia Proprietary Trading Signals
Options skew is bullish (low put/call ratios), which can support short-term bounces.
Revenue growth remains positive in the latest quarter (2025/Q3 +9.29% YoY), indicating demand is still expanding.
Wall Street ratings remain broadly constructive (Buy/Outperform maintained) despite target cuts.
Technicals are decisively bearish (MA stack + expanding negative MACD), making near-term rallies more likely to be sold.
Latest quarter (2025/Q
showed profit pressure: net income -4.74% YoY, EPS -3.81% YoY, gross margin down (-6.74% YoY), which can keep sentiment cautious.
Analysts cut price targets materially after Q3 miss, signaling reduced confidence in near-term trajectory.
No fresh news catalysts in the past week to change the narrative quickly.
Latest quarter: 2025/Q3. Revenue rose to $260.48M (+9.29% YoY), showing continued top-line growth. Profitability weakened: net income fell to $47.19M (-4.74% YoY) and EPS to $1.01 (-3.81% YoY). Gross margin decreased to 42.74 (down 6.74% YoY), indicating cost/mix/inflation/currency pressure. Net takeaway: growth is intact, but margins and earnings momentum softened in the most recent reported quarter.
Recent analyst actions show a clear pattern: multiple firms lowered price targets after the Q3 earnings miss, but generally maintained positive ratings. DA Davidson cut PT to $80 (from $95) while keeping Buy, citing expectation for double-digit 2026 growth but near-term margin/backlog conversion headwinds. Baird cut PT to $72 (from $84) and kept Outperform, emphasizing commercial backlog/vinyl as 2026 drivers. B. Riley cut PT to $70 (from $100) and kept Buy. Wall Street pros: backlog and share capture could drive 2026 growth. Cons: near-term execution/mix and margin pressures plus slower project conversion are weighing on forecasts—hence lower targets.
